Fulcrum Therapeutics, Inc.Fulcrum Therapeutics, Inc.Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics, Inc.

No trades
See on Supercharts

Price target

5.500.000.00%
The 6 analysts offering 1 year price forecasts for FULC have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to FULC in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


FULC EPS for the last quarter is −0.35 USD despite the estimation of −0.40 USD. In the next quarter EPS is expected to reach −0.30 USD. Track more of Fulcrum Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Fulcrum Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Fulcrum Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, FULC price target is 5.50 USD with a max estimate of 14.00 USD and a min estimate of 2.00 USD. Check if this forecast comes true in a year, meanwhile watch Fulcrum Therapeutics, Inc. stock price chart and keep track of the current situation with FULC news and stock market news.
We've gathered opinions of 8 analysts rating FULC stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.